- 210 - 7. To instruct the Executive Secretariat of CICAD: a. To continue to provide assistance to member states that request it to facilitate compliance with the recommendations that flow from the application of the Multilateral Evaluation Mechanism; b. To endeavor to set priorities for the programs carried out by CICAD in all areas, in accordance with the needs of member states; and to explore new technologies and other measures to reduce costs with a view to adjusting to the current financial problems of the Organization; c. To promote adoption of the CICAD Model Regulations for the Control of the International Movement of Firearms, Their Parts and Components, and Ammunition, especially the provisions concerning firearms brokers, adopted at the thirty-fourth regular session of CICAD, held in Montreal, and to advance in the implementation of the Small Arms and Light Weapons Administration System (SALSA) program as an instrument for improving application of the controls set out in the Model Regulations as well as those of the Inter-American Convention against the Illicit Manufacturing of and Trafficking in Firearms, Ammunition, Explosives, and Other Related Materials (CIFTA); d. To continue its training and technical assistance programs and other activities such as mock trials which focus on criminal procedure to facilitate prosecution of money laundering offenses; e. To continue to make efforts to provide technical and financial assistance to member states, with the goal of consolidating the different aspects of institutional and legal strengthening in the field of drug control; f. To continue to promote the creation and strengthening of National Drug Observatories, or national information and research systems on drugs, which are fundamental tools for the strategic planning of national drug policies; g. Through the Inter-American Observatory on Drugs, to support member states in the development and maintenance of uniform data collection systems on the problem of drug use at the national level, in order to be able to measure the problem and follow up on new trends in drug abuse; h. To help member states strengthen control measures to prevent the diversion of pharmaceutical products, controlled chemical substances, and illicitly produced synthetic drugs, and improve the exchange of information on matters related to the application of control measures, in accordance with the plans of action of the Expert Group on Chemicals and the Expert Group on Pharmaceutical Products, as approved at the thirty-fourth regular session of the Commission;

Select target paragraph3

Connect to a paragraph
Connect to an entity
Disable highlights
Add to table of contents